Schizophrenia Trial, Recruiting (NCT06700902)

Schizophrenia Trial, Recruiting NCT06700902 Sponsor: Temple University Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06700902 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are currently enrolled in a 2- or 4-year college or university in the United States and can show a valid student ID card
You are experiencing serious mental health challenges, shown either by scoring 13 or higher on a specific mental health screening questionnaire (the K-6), OR by having been diagnosed with schizophrenia or a major mood disorder and having experienced difficulties in daily life because of your mental health
You are 18 years of age or older
You have regular access to a computer or smartphone with an internet connection
You have never previously taken part in a program called WRAP (Wellness Recovery Action Planning) or "Taking Action"

Who may not be able to join:

You are expected to graduate or finish your program within the next two semesters
You are not able to give your own informed consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2152041699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06700902

Sponsor: Temple University

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 2152041699

More information: https://clinicaltrials.gov/study/NCT06700902

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are currently enrolled in a 2- or 4-year college or university in the United States and can show a valid student ID card
You are experiencing serious mental health challenges, shown either by scoring 13 or higher on a specific mental health screening questionnaire (the K-6), OR by having been diagnosed with schizophrenia or a major mood disorder and having experienced difficulties in daily life because of your mental health
You are 18 years of age or older
You have regular access to a computer or smartphone with an internet connection
You have never previously taken part in a program called WRAP (Wellness Recovery Action Planning) or "Taking Action"

Who may not be able to join:

You are expected to graduate or finish your program within the next two semesters
You are not able to give your own informed consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Temple University

Registry

ClinicalTrials.gov

Start date

1 September 2024

Est. completion

1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes from Baseline in Mental Health Symptoms; Changes from Baseline in Perceived Recovery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov